A new mouse study shows that reducing insulin signaling, specifically in the brain, boosts longevity. The findings help explain two seemingly contradictory observations: people with type 1 diabetes lack insulin-producing cells and must inject the peptide in order to stay healthy. But studies in mice and flies show that reducing insulin lengthens life span.
Scientists genetically engineered mice to dampen part of the insulin-signaling pathway in the brain. The mice lived longer, despite being overweight and having higher blood-glucose levels than normal mice–two characteristics associated with type 2 diabetes in humans.
Exercise and diet can mimic this effect by keeping the body sensitized to insulin, and therefore limiting the brain’s exposure to the hormone. In the future, drugs that target this pathway in the brain might be one approach to stopping the diseases of aging. The findings also suggest that diabetes treatments should focus on sensitizing cells to insulin, rather than on boosting insulin levels all over the body.
How AI is reinventing what computers are
Three key ways artificial intelligence is changing what it means to compute.
These weird virtual creatures evolve their bodies to solve problems
They show how intelligence and body plans are closely linked—and could unlock AI for robots.
Our brains exist in a state of “controlled hallucination”
Three new books lay bare the weirdness of how our brains process the world around us.
We reviewed three at-home covid tests. The results were mixed.
Over-the-counter coronavirus tests are finally available in the US. Some are more accurate and easier to use than others.
Get the latest updates from
MIT Technology Review
Discover special offers, top stories, upcoming events, and more.